ArticleOncology reports2026

Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat.

Hellen Röttgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.